Back to search

Article

<i>Plasmodium falciparum multidrug resistance 1</i>gene polymorphisms associated with outcomes after antimalarial treatment

2024-07-03

Abstract excerpt

<h4>Article summary</h4> This study suggests that: 1) patients given AL infected with parasites carrying N86 were statistically more likely to experience a recurrent infection; 2) patients given ASAQ infected with parasites carrying 86Y were statistically more likely to experience a recurrent infection. <h4>Background</h4> Plasmodium falciparum multidrug resistance transporter 1 ( Pfmdr1 ) gene mutations are assoc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
440f521c-7bd2-5cd2-a175-0e7b2a4e00af
DOI
10.1101/2024.07.01.24309724
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>Plasmodium falciparum multidrug resistance 1</i>gene polymorphisms associated with outcomes after antimalarial treatmentDOI 10.1101/2024.07.01.24309724
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatmentSemantic proximity
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Semantic proximity
Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.Semantic proximity
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.Semantic proximity
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western KenyaSemantic proximity
Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.Semantic proximity
Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.Semantic proximity
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.Semantic proximity
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trialSemantic proximity
Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa.Semantic proximity
Recurrent parasitemias with artemisinin partial resistance mutations during the 2024 Ethiopia malaria resurgence: a case seriesSemantic proximity
Prevalence and distribution of Plasmodium falciparum multidrug resistant 1 D1246Y allele among children in Ibadan Southwest, NigeriaSemantic proximity
Select a neighboring publication to make it the new centre.